[go: up one dir, main page]

NO863458D0 - REPRESSABLE YEAR PROMOTERS. - Google Patents

REPRESSABLE YEAR PROMOTERS.

Info

Publication number
NO863458D0
NO863458D0 NO863458A NO863458A NO863458D0 NO 863458 D0 NO863458 D0 NO 863458D0 NO 863458 A NO863458 A NO 863458A NO 863458 A NO863458 A NO 863458A NO 863458 D0 NO863458 D0 NO 863458D0
Authority
NO
Norway
Prior art keywords
yeast
promoters
repressable
year
hybrid promoters
Prior art date
Application number
NO863458A
Other languages
Norwegian (no)
Other versions
NO175871B (en
NO863458L (en
NO175871C (en
Inventor
Albert Hinnen
Bernd Meyhack
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO863458D0 publication Critical patent/NO863458D0/en
Publication of NO863458L publication Critical patent/NO863458L/en
Publication of NO175871B publication Critical patent/NO175871B/no
Publication of NO175871C publication Critical patent/NO175871C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Alcoholic Beverages (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Graft Or Block Polymers (AREA)
  • Gyroscopes (AREA)
  • Led Devices (AREA)
  • Distillation Of Fermentation Liquor, Processing Of Alcohols, Vinegar And Beer (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Novel upstream activation sites of the yeast PHO5 gene are used to produce inducible yeast hybrid promoters. The yeast hybrid promoters can be used to control transcription of a polypeptide coding region foreign to yeast in a yeast expression vector.
NO863458A 1985-08-29 1986-08-28 Yeast hybrid promoter, yeast hybrid vector, Saccharomyces spec. Host, and method of preparing a yeast polypeptide heterologous NO175871C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858521496A GB8521496D0 (en) 1985-08-29 1985-08-29 Repressible yeast promoters

Publications (4)

Publication Number Publication Date
NO863458D0 true NO863458D0 (en) 1986-08-28
NO863458L NO863458L (en) 1987-03-02
NO175871B NO175871B (en) 1994-09-12
NO175871C NO175871C (en) 1994-12-21

Family

ID=10584428

Family Applications (1)

Application Number Title Priority Date Filing Date
NO863458A NO175871C (en) 1985-08-29 1986-08-28 Yeast hybrid promoter, yeast hybrid vector, Saccharomyces spec. Host, and method of preparing a yeast polypeptide heterologous

Country Status (22)

Country Link
US (1) US5436136A (en)
EP (1) EP0213593B1 (en)
JP (1) JPH07110233B2 (en)
AT (1) ATE62510T1 (en)
AU (1) AU599329B2 (en)
CA (1) CA1318616C (en)
DD (2) DD267739A5 (en)
DE (1) DE3678647D1 (en)
DK (1) DK175093B1 (en)
ES (3) ES2001618A6 (en)
FI (1) FI91280C (en)
GB (1) GB8521496D0 (en)
GR (1) GR862209B (en)
HU (1) HU211207B (en)
IE (1) IE58844B1 (en)
IL (1) IL79837A (en)
NO (1) NO175871C (en)
NZ (1) NZ217388A (en)
PH (1) PH24715A (en)
PT (1) PT83273B (en)
SU (1) SU1630616A3 (en)
ZA (1) ZA866535B (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0245479B1 (en) * 1985-11-13 1993-02-17 Xoma Corporation Shortened phosphoglycerate kinase promoter
GB8530631D0 (en) 1985-12-12 1986-01-22 Ciba Geigy Ag Thrombin inhibitors
MY101203A (en) * 1985-12-12 1991-08-17 Ucp Gen Pharma Ag Production of thrombin iinhibitors.
GB8620926D0 (en) * 1986-08-29 1986-10-08 Delta Biotechnology Ltd Yeast promoter
GB8907110D0 (en) * 1988-05-04 1989-05-10 Ciba Geigy Ag Improvements in the production of polypeptides
NO177065C (en) * 1988-09-26 1995-07-12 Labofina Sa Process for the preparation of enzymatically active human lysozyme
JPH06500470A (en) * 1990-09-04 1994-01-20 メルク　エンド　カンパニー　インコーポレーテッド Production of insulin-like growth factors in methylotrophic yeast cells
US5612198A (en) * 1990-09-04 1997-03-18 The Salk Institute Production of insulin-like growth factor-1 in methylotrophic yeast cells
ATE220105T1 (en) * 1991-04-01 2002-07-15 Merck & Co Inc GENES AFFECTING THE PROTEOLYTIC ACTIVITY OF PICHIA AND THEIR USE
US5674728A (en) * 1993-11-03 1997-10-07 Novartis Corporation Aspergillus niger vacuolar aspartyl protease
JPH08173170A (en) * 1994-05-25 1996-07-09 Kirin Brewery Co Ltd Transformation system of Candida utilis yeast and expression of heterologous gene by it
WO1998013513A2 (en) * 1996-09-24 1998-04-02 Cadus Pharmaceutical Corporation Methods and compositions for identifying receptor effectors
US6265186B1 (en) 1997-04-11 2001-07-24 Dsm N.V. Yeast cells comprising at least two copies of a desired gene integrated into the chromosomal genome at more than one non-ribosomal RNA encoding domain, particularly with Kluyveromyces
US6890730B1 (en) 1999-12-10 2005-05-10 The Salk Institute Sequence and method for increasing protein expression in cellular expression systems
US8008459B2 (en) * 2001-01-25 2011-08-30 Evolva Sa Concatemers of differentially expressed multiple genes
EP2571991A1 (en) 2010-05-20 2013-03-27 Evolva SA Method of producing isoprenoid compounds in yeast
NZ727213A (en) 2012-03-09 2020-03-27 Vestaron Corp Toxic peptide production, peptide expression in plants and combinations of cysteine rich peptides
CA3180326A1 (en) 2020-04-20 2021-10-28 Vestaron Corporation Proteolytically stable u1-agatoxin-ta1b variant polypeptides for pest control
CN116096236A (en) 2020-05-01 2023-05-09 韦斯塔隆公司 Insecticide combination
EP4314025A2 (en) 2021-04-01 2024-02-07 Vestaron Corporation Av3 mutant polypeptides for pest control
WO2023122805A1 (en) 2021-12-20 2023-06-29 Vestaron Corporation Sorbitol driven selection pressure method
TW202413392A (en) 2022-05-18 2024-04-01 美商韋斯塔隆公司 Pesticidal actx peptide variants
WO2023245100A1 (en) 2022-06-17 2023-12-21 Vestaron Corporation Antimicrobial ncr13 variant peptides
WO2024026406A2 (en) 2022-07-29 2024-02-01 Vestaron Corporation Next Generation ACTX Peptides
WO2024259306A2 (en) 2023-06-16 2024-12-19 Vestaron Corporation Pvd1 variant polypeptides for pest control
WO2025226701A1 (en) 2024-04-23 2025-10-30 Vestaron Corporation Proteolytically stable u1-agatoxin-ta1b variant polypeptides for pest control

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2125047B (en) * 1982-08-09 1986-02-19 Ciba Geigy Ag Yeast hybrid vectors and their use for the production of polypeptides
AU577259B2 (en) * 1982-08-13 1988-09-22 Zymogenetics Inc. Glycolytic promters for regulated protein expression protease inhibitor
US4876197A (en) * 1983-02-22 1989-10-24 Chiron Corporation Eukaryotic regulatable transcription
NZ207926A (en) * 1983-04-25 1988-04-29 Genentech Inc Use of yeast #a#-factor to assist in expression of proteins heterologus to yeast
ATE78293T1 (en) * 1983-05-27 1992-08-15 Texas A & M Univ Sys METHOD OF GENERATING A RECOMBINANT BACULOVIRUS EXPRESSION VECTOR.
GB8314961D0 (en) * 1983-05-31 1983-07-06 Kingsman A J Dna sequence
GR80966B (en) * 1983-11-21 1985-03-15 Ciba Geigy Ag Synthesis of fibrinolytic agents by yeast
EP0164556B1 (en) * 1984-05-11 1994-03-02 Chiron Corporation Enhanced yeast transcription employing hybrid promoter region constructs
EP0164566A3 (en) * 1984-05-11 1986-10-29 LGA Gastechnik GmbH Safety device for liquefied-gas tanks
US4895800A (en) * 1985-11-26 1990-01-23 Phillips Petroleum Company Yeast production of hepatitis B surface antigen

Also Published As

Publication number Publication date
DK175093B1 (en) 2004-05-24
GR862209B (en) 1986-12-31
ATE62510T1 (en) 1991-04-15
GB8521496D0 (en) 1985-10-02
EP0213593A1 (en) 1987-03-11
US5436136A (en) 1995-07-25
HU211207B (en) 1995-11-28
HUT42525A (en) 1987-07-28
AU6203286A (en) 1987-03-05
DE3678647D1 (en) 1991-05-16
FI863430A0 (en) 1986-08-25
FI863430L (en) 1987-03-01
CA1318616C (en) 1993-06-01
PT83273A (en) 1986-09-01
IE862307L (en) 1987-02-28
NO175871B (en) 1994-09-12
JPS6251995A (en) 1987-03-06
DK409686A (en) 1987-03-01
NZ217388A (en) 1989-02-24
ZA866535B (en) 1987-04-29
IL79837A0 (en) 1986-11-30
DD254212A5 (en) 1988-02-17
DK409686D0 (en) 1986-08-28
ES2006383A6 (en) 1989-04-16
ES2001618A6 (en) 1988-06-01
SU1630616A3 (en) 1991-02-23
PH24715A (en) 1990-10-01
EP0213593B1 (en) 1991-04-10
DD267739A5 (en) 1989-05-10
AU599329B2 (en) 1990-07-19
FI91280C (en) 1994-06-10
NO863458L (en) 1987-03-02
IL79837A (en) 1992-06-21
IE58844B1 (en) 1993-11-17
NO175871C (en) 1994-12-21
ES2006382A6 (en) 1989-04-16
FI91280B (en) 1994-02-28
JPH07110233B2 (en) 1995-11-29
PT83273B (en) 1989-05-12

Similar Documents

Publication Publication Date Title
NO863458D0 (en) REPRESSABLE YEAR PROMOTERS.
DE3786592D1 (en) TRANSFORMATION OF TRICHODERMA.
GR3021198T3 (en) Interleukin-4 protein having bcgf and tcgf activity on human cells (human interleukin-4)
MY8500760A (en) Polypeptide production by expression in a recombinant microbial cloning vehicle, and cloning vehicles
DE3382760D1 (en) Production of functional human urokinase polypeptides.
DK139493D0 (en) RECOMBINANT PLASMID, BACTERY CULTURE TRANSFORMED THEREOF AND THE USE OF CULTURE
ATE118041T1 (en) DNA CODING FOR FACTOR IX OR ANALOGOUS PROTEIN.
FI852956A0 (en) The method produces a novel human type I interferon protein
ATE142264T1 (en) RECOMBINANT PRODUCTION OF A-CHAIN POLYPEPTIDES OF PDGF
DE3850774D1 (en) BEEF INTERLEUKIN 1 ALPHA.
ATE50597T1 (en) ALPHA INTERFERON GX-1.
ES2089122T3 (en) RECOMBINANT DNA EXPRESSION VECTORS AND DNA COMPOUNDS CODING ISOPENICILLIN N EPIMERASE ACTIVITY.
ES2078229T3 (en) PROCEDURE FOR THE PREPARATION OF A POLYPEPTIDE SIMILAR TO MOTILINE AND ITS EXPRESSION.
DK541283D0 (en) GAS REGULATOR WITH SERVO PRESSURE CONTROLLER
ATE96169T1 (en) RECOMBINANT HOSTS, THEIR PRODUCTION AND USE.
FI832333A7 (en) A microorganism transformed with a recombinant cloning vector, a microbial culture containing the transformed microorganism, and a method for producing a heterologous polypeptide

Legal Events

Date Code Title Description
MK1K Patent expired